Harrison, Shelby R.

Shelby R. Harrison

Associate

shelby.harrison@lw.com
    Harrison, Shelby R.

    Shelby R. Harrison

    Associate

    shelby.harrison@lw.com

    Profile

    Shelby Harrison is an associate in the San Diego office of Latham & Watkins and a member of the firm’s Corporate Department.

    Shelby represents public and private companies in a wide variety of corporate matters, including public securities offerings, corporate governance, mergers and acquisitions, and securities law and stock exchange compliance matters. Shelby also advises investment banks on capital market offerings by public companies. She also co-authors the Annual Meeting Handbook, which is published annually and distributed nationwide.

    Shelby graduated from UCLA School of Law, where she was elected to the Order of the Coif. She received five Masin Family Academic Excellence Awards. 

    Prior to joining Latham, Shelby served as a judicial extern to Judge Thomas J. Whelan of the US District Court for the Southern District of California.

    Experience

    Shelby has advised on a broad range of corporate transactions, including initial public offerings, follow-on offerings, PIPE financings, and at-the-market offerings, as well as mergers and acquisitions and general public company representation matters.

    Significant matters include representing:

    • HilleVax, Inc. in its initial public offering and equity offerings
    • Icosavax, Inc. in its initial public offering, equity offerings, and US$1 billion sale to AstraZeneca
    • Topgolf Callaway Brands Corp. in its equity offerings and its acquisition of BigShots Golf 
    • Virgin Galactic Holdings, Inc. in its equity offerings
    • Erasca, Inc. in its initial public offerings and equity offering
    • Gossamer Bio, Inc. in its equity offerings
    • Evoke Pharma, Inc. in its equity offerings
    • eFFECTOR Therapeutics, Inc. in its de-SPAC transaction and equity offerings
    • Crinetics Pharmaceuticals, Inc. in its equity offerings
    • The underwriters in public equity offerings for life sciences companies, including Longboard Pharmaceuticals, Inc., Immunome, Inc., Chimerix, Inc., Cidara Therapeutics, Inc., Harpoon Therapeutics, Inc., Intellia Therapeutics, Inc., Eiger Biopharmaceuticals, Inc., Spero Therapeutics.  Inc., Black Diamond Therapeutics, Inc., ImmunoGen, Inc., and Omeros Corporation

    Qualifications

    Bar Qualification

    • California

    Education

    • JD, University of California, Los Angeles School of Law, 2020
      Order of the Coif
    • BA in Political Science, University of California, San Diego, 2016
      cum laude

    Practices

    News & Insights

    Read More